NUTRA PHARMA CORP

Near-insolvent micro-cap with deep operating losses.

Strengths

• n/a — no durable positives

Risks

• Near-insolvent liquidity — current ratio 0.0 (7th)
• Deep losses — operating margin -568%
• Going-concern fragility — per 10-K

Notable findings

• No interest coverageInterest coverage -63.94 (cannot cover interest)
• Going concernWe have a significant working capital deficiency, and have not reached a profitable level of operations, which raises substantial doubt about our ability to continue as a going concern
• Cash burnNegative free cash flow (-1.2M)
• Negative equityNegative book equity (debt/equity -0.01)
• Material weaknessWe have identified material weaknesses in our internal control over financial reporting, which could adversely affect our financial condition, access to capital, and the market price of our common sto
• Weak liquidityCurrent ratio 0.03 (<1)
• Net lossNet loss (net margin -794.8%)